Alnylam Pharmaceuticals Inc (ALNY)

121.84 +1.13  +0.94% NASDAQ Dec 10, 20:00 Delayed 2m USD

Alnylam Pharmaceuticals Cash from Operations (TTM):

-232.90M for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 2003. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 -232.90M
June 30, 2019 -204.08M
March 31, 2019 -595.46M
Dec. 31, 2018 -562.62M
Sept. 30, 2018 -515.20M
June 30, 2018 -459.76M
March 31, 2018 -438.12M
Dec. 31, 2017 -382.79M
Sept. 30, 2017 -358.08M
June 30, 2017 -335.25M
March 31, 2017 -324.41M
Dec. 31, 2016 -307.70M
Sept. 30, 2016 -282.43M
June 30, 2016 -261.26M
March 31, 2016 -246.51M
Dec. 31, 2015 -189.14M
Sept. 30, 2015 -172.71M
June 30, 2015 -159.05M
March 31, 2015 -150.22M
Dec. 31, 2014 -165.64M
Sept. 30, 2014 -151.38M
June 30, 2014 -132.38M
March 31, 2014 -109.36M
Dec. 31, 2013 -68.66M
Sept. 30, 2013 -115.20M
   
June 30, 2013 -88.27M
March 31, 2013 -86.36M
Dec. 31, 2012 -115.61M
Sept. 30, 2012 -71.86M
June 30, 2012 -106.09M
March 31, 2012 -110.98M
Dec. 31, 2011 -87.07M
Sept. 30, 2011 -82.30M
June 30, 2011 -77.31M
March 31, 2011 -75.04M
Dec. 31, 2010 -84.34M
Sept. 30, 2010 -80.82M
June 30, 2010 -77.37M
March 31, 2010 -88.98M
Dec. 31, 2009 -72.14M
Sept. 30, 2009 -60.12M
June 30, 2009 -55.55M
March 31, 2009 75.38M
Dec. 31, 2008 65.49M
Sept. 30, 2008 61.90M
June 30, 2008 302.22M
March 31, 2008 198.82M
Dec. 31, 2007 196.52M
Sept. 30, 2007 200.34M
June 30, 2007 -26.90M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Operations

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More

Advertisement

Cash from Operations (TTM) Benchmarks

Benchmarks
The Medicines Co -198.34M
Regeneron Pharmaceuticals Inc 2.371B
Amgen Inc 9.83B

Cash from Operations (TTM) Range, Past 5 Years

Minimum -595.46M Mar 2019
Maximum -150.22M Mar 2015
Average -317.17M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.